Marwan Sabbagh - 08 Jun 2026 Form 4 Insider Report for CervoMed Inc. (CRVO)

Reporting relationship: Director
Issuer ticker: CRVO
Reported as of: 08 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2026, 19:44:43 UTC
Prior SEC filing: 25 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person

Key filing fact

Marwan Sabbagh filed Form 4 for CervoMed Inc. (CRVO) on 10 Jun 2026.

Key facts

This page summarizes Marwan Sabbagh's Form 4 filing for CervoMed Inc. (CRVO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2026, 19:44.

Change

Previous filing in this sequence was filed on 25 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001917672 Primary reporting owner

Sabbagh Marwan

Relationship: Director
Address: 20 PARK PLAZA, SUITE 424, BOSTON
Signature: /s/ William R. Elder, attorney-in-fact for the Reporting Person
Signature date: 10 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +8,150
Change %
Price: $0.000000^*
Shares after: 8,150
Date: 08 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,150
Exercise price: $2.91
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date.